Xylem (NYSE:XYL) Stock Price Target Cut by Citigroup

Xylem (NYSE:XYL) had its price target dropped by Citigroup from $148.00 to $130.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the industrial products company’s stock. Citigroup‘s price target points to a potential upside of 47.20% from the stock’s previous close.

Several other equities analysts have also weighed in on XYL. Wolfe Research initiated coverage on Xylem in a report on Tuesday, September 15th. They set a “peer perform” rating for the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Xylem in a research report on Wednesday, August 5th. JPMorgan Chase & Co. downgraded shares of Xylem from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $118.00 to $90.00 in a research note on Wednesday. UBS Group lowered their price target on shares of Xylem from $138.00 to $112.00 and set a “neutral” rating on the stock in a research report on Monday, October 5th. Finally, Mizuho set a $99.00 price target on shares of Xylem in a research note on Wednesday. Ten equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and an average target price of $128.21.

Xylem Stock Performance

XYL stock traded down $4.54 during mid-day trading on Wednesday, hitting $88.31. The company had a trading volume of 4,942,934 shares, compared to its average volume of 2,146,082. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61. The firm has a market cap of $20.62 billion, a PE ratio of 21.03, a price-to-earnings-growth ratio of 1.75 and a beta of 1.00. Xylem has a 12 month low of $87.40 and a 12 month high of $154.27. The stock’s fifty day moving average price is $106.50 and its two-hundred day moving average price is $118.31.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.45 by ($0.01). The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.28 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%. The company’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.37 EPS. On average, analysts forecast that Xylem will post 5.65 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. XXEC Inc. bought a new stake in shares of Xylem during the second quarter valued at about $850,841,000. BlackRock Inc. bought a new position in shares of Xylem in the second quarter valued at approximately $2,959,730,000. Bank of New York Mellon Corp bought a new position in shares of Xylem in the second quarter valued at approximately $552,313,000. Hsbc Holdings PLC purchased a new position in Xylem during the second quarter valued at approximately $319,785,000. Finally, Deutsche Bank AG purchased a new position in Xylem during the second quarter valued at approximately $223,165,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Trending Headlines about Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Third-quarter adjusted earnings increased year over year to $1.44 per share, and orders reportedly grew 10%, suggesting underlying demand remains resilient in some markets. Xylem Q3 2026 results
• Positive Sentiment: Several analysts still view the selloff as excessive. BNP Paribas Exane, Stifel Nicolaus and Oppenheimer maintained “outperform” or “buy” ratings, with revised targets of $135, $114 and $135, respectively—well above the current trading level. Analyst ratings
• Neutral Sentiment: Xylem plans portfolio divestitures and a segment restructuring. These actions could improve focus and efficiency over time, but may create near-term execution costs and uncertainty. Xylem restructuring plans
• Negative Sentiment: Third-quarter revenue was $2.20 billion, about $80 million below expectations and down 3% year over year. EPS of $1.44 also missed consensus, reflecting weakness in metering and delays or softness in project activity. Xylem Q3 earnings miss
• Negative Sentiment: Management cut its 2026 revenue and profit outlook and issued weak fourth-quarter expectations, raising concerns that customers are delaying purchases and that the slowdown may persist. Xylem outlook reduction
• Negative Sentiment: JPMorgan downgraded Xylem to “underweight” from “neutral” and cut its price target to $90 from $118. RBC and Oppenheimer also lowered targets, reinforcing concerns about earnings estimates. JPMorgan Xylem downgrade
• Negative Sentiment: Put-option purchases were roughly 358% above typical volume, signaling heightened downside hedging or bearish speculation. A law firm also announced an investigation into potential securities-law violations following the earnings-related losses. Xylem investigation notice

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.